Anti-tumorigenic effect of combination treatment with ONC201 and TRAIL in endometrial cancer in vitro and in vivo

被引：0
|
作者：
Ray, J. [1 ]
Ralff, M. [1 ]
Jhaveri, A. [2 ]
El-Deiry, W. [2 ]
机构：
[1] Fox Chase Canc Ctr, 7701 Burholme Ave, Philadelphia, PA 19111 USA
[2] Brown Univ, Women & Infants Hosp, Providence, RI USA
来源：
GYNECOLOGIC ONCOLOGY | 2020年 / 159卷
关键词：
D O I：
10.1016/j.ygyno.2020.06.158
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
85
引用
收藏
页码：76 / 77
页数：2
相关论文
共 50 条
  • [21] Role of ClpP in the anti-cancer effects of imipridone ONC201 and ONC206
    Lee, Andrew
    Maranto, Cristina
    Foster, Scott
    Morrow, Sara
    Allen, Joshua E.
    Lanier, Randall
    Sethna, Phiroze
    Prabhu, Varun V.
    CANCER RESEARCH, 2023, 83 (07)
  • [22] Docosahexaenoic acid demonstrates anti-tumorigenic effects in endometrial cancer
    O'Donnell, Jillian A.
    Buckingham, Lindsey K.
    Pierce, Stuart R.
    West, Lindsay
    Yin, Yiajie
    Sun, Wenchuan
    Fang, Ziwei
    Lee, Douglas
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (02) : 395 - 396
  • [23] Anti-tumorigenic effects of phenformin in human endometrial cancer cells
    Jackson, Amanda L.
    Kilgore, Joshua E.
    Qiu, Haifeng
    Zhou, Chunxiao
    Gehrig, Paola A.
    Bae-Jump, Victoria L.
    CANCER RESEARCH, 2014, 74 (19)
  • [24] The angular structure of ONC201, a TRAIL pathway-inducing compound, determines its potent anti-cancer activity
    Wagner, Jessica
    Kline, Christina Leah
    Pottorf, Richard S.
    Nallaganchu, Bhaskara Rao
    Olson, Gary L.
    Dicker, David T.
    Allen, Joshua E.
    El-Deiry, Wafik S.
    ONCOTARGET, 2014, 5 (24) : 12728 - 12737
  • [25] Anti-cancer efficacy of imipridones in pancreatic cancer: single agent ONC212 or combination of ONC201 with IGF1-R inhibition
    Lev, Avital
    Lulla, Amriti R.
    Wagner, Jessica
    Dicker, David T.
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2017, 77
  • [26] Antitumor efficacy of combination treatment with ONC201 and enzalutamide or darolutamide in metastatic castration-resistant prostate cancer
    Wu, Jinxuan Laura
    Zhou, Lanlan
    Zhang, Leiqing
    Huntington, Kelsey E.
    Carneiro, Benedito
    El-Deiry, Wafik S.
    CANCER RESEARCH, 2022, 82 (12)
  • [27] Treatment and signaling contexts for the application of the imipridone ONC201 to prostate cancer cells
    Amoroso, Francesca
    Pickard, Adam
    Glass, Kimberly
    Tarapore, Rohinton
    Allen, J. E.
    Mills, Ian G.
    CANCER RESEARCH, 2018, 78 (13)
  • [28] Docosahexaenoic acid demonstrates anti-tumorigenic effects in endometrial cancer.
    O'Donnell, Jillian A.
    Buckingham, Lindsey K.
    Pierce, Stuart R.
    West, Lindsay
    Yin, Yiajie
    Sun, Wenchuan
    Fang, Ziwei
    Lee, Douglas P.
    Zhou, Chunxiao
    Bae-Jump, Victoria L.
    CLINICAL CANCER RESEARCH, 2021, 27 (03)
  • [29] Dopamine pre-treatment impairs the anti-cancer effect of integrated stress response- and TRAIL pathway-inducing ONC201, ONC206 and ONC212 imipridones in pancreatic, colorectal cancer but not DMG cells
    Zhang, Yiqun
    Tapinos, Nikos
    Lulla, Rishi
    El-Deiry, Wafik S.
    AMERICAN JOURNAL OF CANCER RESEARCH, 2024, 14 (05):
  • [30] CYP450 AND METABOLIC PROFILING OF ANTI-CANCER IMIPRIDONE ONC201
    Morrow, Sara
    Prabhu, Varun
    Tarapore, Rohinton S.
    Guo, Ailan
    Fang, Yunlan
    Nej, Magdalena
    Stogniew, Martin
    Allen, Joshua
    NEURO-ONCOLOGY, 2020, 22 : 102 - 102
12345